Survey on Paediatric Differentiated Thyroid Cancer Care in Europe

Bernadette L Dekker1, Kate L Newbold2, Dagmar Führer3

  • 1Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Insights

Paediatric thyroid cancer management varies across Europe, highlighting the need for international collaboration. A European network is essential to optimize treatment and improve outcomes for childhood thyroid cancer survivors.

Area of Science:

  • Pediatric Endocrinology
  • Oncology
  • Public Health Policy

Background:

  • Thyroid cancer in children is rare but associated with significant treatment morbidity.
  • Optimizing management for pediatric thyroid cancer requires international cooperation.
  • The 2016 European Thyroid Association-Cancer Research Network (ETA-CRN) meeting focused on this patient group.

Purpose of the Study:

  • To provide an overview of pediatric thyroid cancer care across European countries.
  • To identify variations in treatment and organization of care.
  • To advocate for enhanced European collaboration.

Main Methods:

  • A survey was conducted using questionnaires.
  • Data collected focused on treatment protocols and care organization.
  • The study inventoried current practices in European countries.

Main Results:

  • Paediatric thyroid cancer treatment is fragmented across Europe.
  • Centralization of care is limited.
  • Significant differences exist in treatment and follow-up protocols among European nations.

Conclusions:

  • A collaborative European network is crucial for optimizing treatment.
  • Minimizing long-term consequences for survivors necessitates coordinated efforts.
  • The ETA-CRN supports establishing a European network for this rare endocrine cancer.
Abstract